Treating Tobacco Dependence in Persons with Mental Illness: Identifying Challenges and Opportunities
Select a Webinar Format:
 PDF with evaluation and certificate
       $0.00 for APNA Members
       $15.00 for Non-Members

In order to register, you must log in. Use the login form at the top of the left-hand column.

Nurses need guidance on how to address the challenges and barriers that inhibit or prevent integration of tobacco dependence interventions that are effective, efficient, and practical in both the inpatient and outpatient settings. This third issue of Counseling Points - Breaking Barriers and Implementing Change will identify barriers and challenges that nurses face in delivering effective tobacco dependence interventions across the continuum of care and it will explain how nurses can address challenges and work toward reducing the barriers that inhibit the delivery of effective tobacco dependence interventions.


Daryl Sharp, PhD, PMHCNS-BC, NPP
Director, Doctor of Nursing Practice Program
Associate Professor of Clinical Nursing and in the Center for Community Health
University of Rochester Medical Center
Rochester, New York


Madeline A. Naegle, APRN, BC, PhD, FAAN
Professor and Coordinator, Advanced Practice Nursing: Psychiatric-Mental Health
Director, New York University College of Nursing, International Programs
Director, New York University, World Health Organization Collaborating Center for Geriatric Nursing Education
New York, New York


Victoria Palmer-Erbs, PhD, APRN, BC
Associate Professor of Nursing
College of Nursing and Health Sciences
University of Massachusetts Boston
Boston, Massachusetts


Steven A. Schroeder, MD
Department of Medicine and Smoking Cessation Leadership Center
University of California, San Francisco
San Francisco, California


Georgia L. Stevens, PhD, APRN, PMHCNS, BC
Geropsychiatric Nurse Coordinator
Baltimore Mental Health Systems & Maryland Mental Hygiene Adminsitration
Baltimore, Maryland


APNA and Faculty/Authors Disclosure Statements:
Accredited status of an activity does not imply APNA or ANCC Commission on Accreditation endorsement of commercials products.  Georgia Stevens discloses that she has received honoraria and served on a Speakers' Bureau for Janssen Pharmaceuticals. Madeline Naegle, Victoria Palmer-Erbs, Steven Schroeder, and Daryl Sharp have no conflicts to disclose.


Target Audience
This educational activity is designed to meet the needs of psychiatric nurses with an interŽest in providing quality care to consumers with mental illness who smoke and/or use other tobacco products.


Learning Objectives
Upon completion of this educational activity, the participant should be able to:

1. Identify the barriers and challenges that nurses face in providing tobacco dependence interventions in healthcare delivery systems.
2. Describe nursing strategies to address the challenges that deter the delivery of eviŽdence-based tobacco dependence interventions.
3. Describe nursing strategies to reduce the barriers to the delivery of evidence-based tobacco dependence interventions.


Continuing Education Credit

1.0 contact hour may be earned for successful completion of this activity. * In order to receive contact hours, you must:  Read the entire publication, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to earn a score of 80% or better on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.

The contact hours for this continuing education activity will expire on December 31, 2012.


The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. The American Psychiatric Nurses Association, Delaware Media Group, and Pfizer, Inc. do not recommend the use of any agent outside of the FDA-approved labeled indications. The opinions expressed in this educational activity are those of the faculty/authors and do not necessarily represent the views of the American Psychiatric Nurses Association, Delaware Media Group, or Pfizer, Inc.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other healthcare professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.